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Supporting recovery in patients with psychosis through care 
by community-based adult mental health teams (REFOCUS): 
a multisite, cluster, randomised, controlled trial
 Mike Slade, Victoria Bird, Eleanor Clarke, Clair Le Boutillier, Paul McCrone, Rob Macpherson, Francesca Pesola, Genevieve Wallace, Julie Williams, 
Mary Leamy
Summary
Background Mental health policy in many countries is oriented around recovery, but the evidence base for service-
level recovery-promotion interventions is lacking.
Methods We did a cluster, randomised, controlled trial in two National Health Service Trusts in England. REFOCUS 
is a 1-year team-level intervention targeting staff  behaviour to increase focus on values, preferences, strengths, and 
goals of patients with psychosis, and staff –patient relationships, through coaching and partnership. Between April, 
2011, and May, 2012, community-based adult mental health teams were randomly allocated to provide usual treatment 
plus REFOCUS or usual treatment alone (control). Baseline and 1-year follow-up outcomes were assessed in randomly 
selected patients. The primary outcome was recovery and was assessed with the Questionnaire about Processes of 
Recovery (QPR). We also calculated overall service costs. We used multiple imputation to estimate missing data, and 
the imputation model captured clustering at the team level. Analysis was by intention to treat. This trial is registered, 
number ISRCTN02507940.
Findings 14 teams were included in the REFOCUS group and 13 in the control group. Outcomes were assessed in 
403 patients (88% of the target sample) at baseline and in 297 at 1 year. Mean QPR total scores did not diff er between 
the two groups (REFOCUS group 40·6 [SD 10·1] vs control 40·0 [10·2], adjusted diff erence 0·68, 95% CI –1·7 to 3·1, 
p=0·58). High team participation was associated with higher staff -rated scores for recovery-promotion behaviour 
change (adjusted diff erence –0·4, 95% CI –0·7 to –0·2, p=0·001) and patient-rated QPR interpersonal scores (–1·6, 
–2·7 to –0·5, p=0·005) at follow-up than low participation. Patients treated in the REFOCUS group incurred £1062 
(95% CI –1103 to 3017) lower adjusted costs than those in the control group.
Interpretation Although the primary endpoint was negative, supporting recovery might, from the staff  perspective, 
improve functioning and reduce needs. Implementation of REFOCUS could increase staff  recovery-promotion 
behaviours and improve patient-rated recovery.
Funding National Institute for Health Research.
Introduction
An orientation towards supporting personal recovery is 
national mental health policy in England and Wales,1 and 
throughout much of the English-speaking world. This 
focus on recovery has been reiterated in the UK Chief 
Medical Offi  cer’s report on public mental health.2 In this 
context, personal recovery is defi ned as a way of living a 
satisfying and hopeful life, including contribution to 
society, even with any limitations caused by illness.3 This 
modern meaning of recovery can be contrasted with the 
traditional focus of clinical recovery on symptoms and 
disability. Epidemiological evidence indicates that most 
people with mental illnesses will achieve clinical recovery 
in the long term.4
Scientifi c knowledge about interventions to support 
personal recovery is expanding, with reviews available of, 
for example, vocational rehabilitation, peer support, and 
advance directives.5 Programmes are underway inter-
nationally to support recovery-promotion system trans-
formation.6 Despite this progress, policy is substantially 
ahead of research and practice. To catch up, new evidence-
based interventions will need to be introduced and 
changes made in staff –patient relation ships, treat ment 
(eg, with emerging evidence that psychosocial inter-
ventions for psychosis could be eff ective without pharma-
cotherapy),7 and assessment by expanding diversity in 
outcomes (eg, employment and personal relation ships in 
addition to traditional outcomes, such as symptoms and 
functioning).8 Initiatives are needed at all levels within 
the system, not just the staff –patient level, to achieve 
changes in organisational culture that will support 
recovery.
We assessed the usefulness of the REFOCUS team-
level intervention to support personal recovery9 informed 
by the theory of planned behaviour.10 This theory proposes 
that behavioural intent is aff ected by attitudes, subjective 
norms, and the perceived degree of behavioural control. 
Meta-analysis of health research suggests that the 
theory accounts for over 20% of actual behaviour.11 The 
REFOCUS intervention is intended to be suitable for 
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various diagnoses and all types of community-based adult 
mental health teams. An international review found that 
staff  can support recovery through what they do with 
patients (the supporting recovery practice domain) and 
how they work with patients (the working relationship 
practice domain).12 Thus, the intervention targets care 
content (what) by supporting the use of three working 
practices, as described in the methods, and care processes 
(how) through training staff  in coaching and giving 
opportunities for other recovery-promoting relationships. 
The intervention and assessments are based on the 
REFOCUS model, which is described in the intervention 
manual.9 Following the Medical Research Council 
framework for complex health interventions,13 the model 
specifi es the intended causal pathway from intervention, 
through changes in practice and the patient’s experiences, 
to recovery. We compared outcomes for patients receiving 
treatment from community-based adult mental health 
teams, with or without the REFOCUS intervention. We 
focused on the eff ects in patients with psychosis, with the 
aim of providing evidence to inform disorder-specifi c 
clinical guidelines. We tested the hypothesis that the 
REFOCUS intervention would be associated with 
improved recovery compared with usual care.
Methods
Study design and participants
We did a cluster, randomised, controlled trial that 
involved two mental health National Health Service 
(NHS) Trusts in England, between April, 2011, and May, 
2012. The trial manual9 and protocol of the study14 have 
been previously published. Ethics approval was obtained 
from the East London Research Ethics Committee. 
Researchers were trained in administration of all 
standardised measures, and trial conduct was overseen 
by a trial steering committee (appendix).
As the intervention is at the team level, we used a 
cluster design, with a cluster being a mental health team 
(the unit of service delivery in the NHS), to keep con-
tamination to a minimum. Team inclusion criteria were 
com munity-based adult mental health teams providing 
care coordination for adults with the care programme 
approach,15 which is a national framework for care 
coordination and resource allocation in mental health 
care. Teams were recruited from the South London and 
Maudsley NHS Foundation Trust (SLaM) in southeast 
London, and the 2gether NHS Foundation Trust in 
Gloucestershire. SLaM is the largest mental health trust 
in the UK and has an annual income of £330 million 
spent across over 100 sites in urban and suburban 
settings. It employs 4500 staff  in 296 teams and works 
with 34 128 service users. 2gether is a rural and semi-rural 
trust that employs 806 staff  in 23 adult mental health 
teams and works with 4301 service users. Potentially 
eligible teams were identifi ed by service managers, after 
which researchers discussed partici pation with the service 
and team managers and lead clinicians.
Eligible patients were aged 18–65 years, had a primary 
clinical diagnosis of psychosis (eg, schizophrenia, 
schizoaff ective disorder, or bipolar disorder) with no 
immediate plans for discharge or transfer, were not 
currently receiving inpatient care, were not in prison, 
spoke and understood English, were not participating in 
any other substantial study, were deemed by their 
clinicicans to be suffi  ciently well to participate, and were 
in regular contact with at least one worker in the mental 
health team (as judged by the team). Exclusion criteria 
were being unable to give consent or being unknown to 
or uncontactable by the service. Each team’s clinical 
records were screened for initial eligibility (age and 
diagnosis). Clinicians obtained permission from patients 
to be approached by researchers, who established 
eligibility. Written informed consent and baseline data 
were obtained from participants by researchers before 
randomisation.
Staff  inclusion criteria were providing clinical input to 
a participating team (only one team for staff  who were 
suggested as key informants by patients) and being in 
regular clinical contact with the participating service 
user. All staff  gave written informed consent and 
completed baseline assessments before randomisation.
Randomisation and masking
Teams were allocated equally to usual treatment plus the 
REFOCUS intervention or to usual treatment alone 
(control), stratifi ed by allocation wave to the four SLaM 
boroughs and two 2gether localities to ensure balance. 
Block randomisation of teams was undertaken by the 
independent Mental Health and Neuroscience Clinical 
Trials Unit. For each team, the screened cases of 
potentially eligible patients were randomly ordered, 
according to procedures set out by the Mental Health and 
Neuroscience Clinical Trials Unit, and were recruited in 
the order of that list. Participating staff , patients, and 
researchers were aware of allocation status.
Procedures
All teams were multidisciplinary and provided care 
coordination under the care programme approach, in 
which systematic arrangements for assessing health and 
social needs, formation of a care plan identifying the 
health and social care needed from various providers, 
appointment of a key worker to monitor and coordinate 
care, and regular review of the care plan are important 
features. Teams allocated to the REFOCUS group re-
ceived training in the REFOCUS intervention.9 Briefl y, 
REFOCUS is a 1-year intervention that involves the whole 
team and takes into account the values of teams and 
individual staff  members (which can be confl icting)16 
recovery-related knowledge, skills and behaviour, and 
staff –patient relationships. The intervention has behav-
ioural and interpersonal components. The behavioural 
component comprises three desired behaviours by staff , 
called working practices. Working practice 1 involves 
See Online for appendix
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under standing patients’ values and identity beyond being 
a patient and placing patients’ preferences at the centre of 
planning care. Working practice 2 involves assessing 
patients’ personal and social strengths with a standard 
approach to identify existing and potential resources on 
which the patient can build. Working practice 3 involves 
supporting patients in striving for goals by orienting 
clinical care around goals valued by the patient. Working 
practices are fulfi lled in the context of the interpersonal 
component (called recovery-promoting relationships) and 
includes training staff  to use coaching skills in interactions 
with patients17 and to start partnership projects, in which 
staff  and patients take on joint non-clinical tasks, with a 
small resource of £500 for each team.
Implementation of REFOCUS was supported by 
meetings and training. Intervention briefi ng meetings 
about the study were held separately for patients and 
informal carers and for staff . The following training and 
support meetings were off ered to staff : 12 h (three 4 h 
sessions) of training in personal recovery provided by 
two trainers (one with a professional background and 
one with a service-use background); 16 h (one 8 h and 
two 4 h sessions) of training in recovery coaching from a 
coaching trainer, with telephone support and optional 
booster sessions; six externally facilitated team-manager 
refl ection groups to support culture change; six team 
refl ection groups (three externally facilitated, three not 
facilitated) to foster experiential learning; and the use of 
a refl ective practice tool in individual supervision.
Outcomes
The primary outcome was recovery, which was assessed 
with the Questionnaire about the Process of Recovery 
(QPR).18 This measure was deemed appropriate on the 
basis of a systematic review.19 QPR is a 22-item patient-
rated assessment of recovery, developed from a qualitative 
study led by service-user researchers.20 Example items 
are “I can actively engage with life” and “I am able to 
develop positive relationships with other people”. Each 
item is rated on a fi ve-point scale from 0 (disagree 
strongly) to 4 (agree strongly). The initial version 
comprised two subscales, QPR intrapersonal (17 items 
with a score range of 0–68) and QPR interpersonal (fi ve 
items with a score range of 0–20), with higher scores 
indicating increased recovery. Adequate internal con-
sistency (intrapersonal 0·94 and interpersonal 0·77), 
construct validity, and test-retest reliability (intrapersonal 
0·87 and interpersonal 0·76) were shown.18 Subsequently, 
one 15-item questionnaire with a score range of 
0–60 (QPR total) was developed that had internal 
consistency of 0·93 and test-retest reliability of 0·70.21 
Signifi cant correlation was shown between the 15-item 
QPR and the standard measures of symptoms, hope, and 
self-esteem.21 In this study we calculated QPR total, 
intrapersonal, and interpersonal scores for patients.
To measure the secondary outcomes of hope, quality of 
life, empowerment, wellbeing, and met and unmet needs 
in patients, we used, respectively, the Herth Hope Index, 
Manchester Short Assessment of Quality of Life 
(MANSA) questionnaire, Mental Health Confi dence 
Scale, Warwick-Edinburgh Mental Well-Being Scale, and 
Camberwell Assessment of Needs Short Appraisal 
Schedule-Patient (CANSAS-P). To measure experience 
(satisfaction and recovery support) in patients, we used 
the Client Satisfaction Questionnaire and INSPIRE. To 
measure staff -rated outcomes (met and unmet needs, 
functioning, and social disability), we used CANSAS-
Staff  (CANSAS-S), the Global Assessment of Functioning 
(GAF), and the Health of the Nation Outcome Scale 
(HoNOS). Researchers rated symptoms with the Brief 
Psychiatric Rating Scale and service use with the Client 
Service Receipt Inventory.
For the quantitative elements of assessment, all staff  
completed measures of their recovery-related knowledge 
and attitudes with the Recovery Knowledge Inventory 
(RKI), attitudes towards mental illness with the Mental 
Illness: Clinicians’ Attitudes (MICA) questionnaire, and 
two non-standardised measures, the Participation Scale 
and the Recovery Practice Scale. The Participation Scale 
was used to rate attendance and engagement with 
personal recovery training, coaching training, and team 
refl ection sessions. The Recovery Practice Scale was used 
to assess self-rated skills, behavioural intent, and 
behaviour in relation to coaching, values, strengths, 
striving to achieve goals, and partnership relationships. 
Details of all measures are provided in the appendix.
Data were collected by researchers who were trained in 
all measures. Teams were contacted 4 months before 
allocation to start collection of baseline data, although 
most information was collected in the month before 
allocation. Patients completed questionnaires during 
meetings with researchers and each identifi ed his or her 
care coordinator or another appropriate paired pro-
fessional in the mental health team. Researchers 
completed the Brief Psychiatric Rating Scale and Client 
Service Receipt Inventory, while with patients and the 
identifi ed paired staff  were approached and asked to 
complete CANSAS-S, HoNOS, and GAF separately. 
Teams were allocated to study groups after all baseline 
question naires were completed. 1 year after randomi-
sation, all assessments were repeated, with staff  in the 
REFOCUS group also completing the Participation 
Scale. Follow-up data for patients were sought irrespective 
of any changes in circumstances (eg, team disbanded, 
discharge, move to a new NHS Trust, imprisonment, or 
change to inpatient status). Most data were collected 
within 1 month. Patients were off ered £10 for their time 
after attendance at each assessment, and could be 
entered into a £50 prize draw. Staff  data were collected 
from the same member of staff  where possible, otherwise 
they were collected from an appropriate alternative team 
member.
Data recorded on paper forms were transcribed to an 
electronic database that the researchers were trained to 
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use. A data entry protocol was followed to ensure 
consistency and data validation rules were applied to 
reduce transcription errors. All identifi cation numbers 
were checked to ensure matches between data, and all 
data fl agged as missing were checked manually to 
confi rm. A random 20% sample of patient-rated (QPR, 
Client Satisfaction Questionnaire, and CANSAS-P) and 
staff -rated (CANSAS-S, GAF, HoNOS, MICA, RKI,  and 
Recovery Practice Scale) follow-up data were manually 
checked against paper copies and showed agreement of 
99·66% and 99·75%, respectively.
The REFOCUS cost analysis was based on the staff  
time involved in delivering the intervention combined 
with the unit costs for those staff  members, which were 
derived from those reported by Curtis22 and NHS 
reference costs (appendix). The resulting values were 
divided by number of cases per team to derive the cost 
per service user. This approach is conservative because it 
assumes that the training will only benefi t current service 
users. If it were assumed that future services users could 
also benefi t, the cost would be reduced. Other service use 
data included contacts with primary and secondary 
health-care services (including days in hospital) and 
social care. No imputation was used for loss to follow-up 
because this occurred for a small number of cases across 
a wide range of services. To allow calculation of total 
costs, however, we used a standard economic assessment 
approach that when a service was used but the number 
of contacts was not recorded, data were imputed with 
median values from complete cases.
Statistical analysis
All analyses were done with Stata (version 11). We 
calculated that 29 teams (with 17% attrition to 24 teams), 
336 patients (15 patients per team with 7% attrition to 
14 per team), and an estimated team-level intracluster 
correlation of 0·05 (a conservative estimate of the 
similarities of teams),23 would be suffi  cient to achieve 
80% power to show a medium standardised eff ect size of 
0·4 at α=0·05.
Missing data (other than for the six patients who died 
during follow-up) were estimated with multiple (50) 
imputations by chained equation (Stata MICE com-
mand). The imputation model refl ected clustering at 
team level and, as multiple imputation relies on the 
assumption that data are missing at random, included 
baseline outcome measures and covariates to improve 
the estimation of missing values. Sensitivity analyses 
showed that the distributions of the imputed items and 
complete cases were similar, yielded equivalent result 
patterns, and that analyses based on missing data 
imputed for outcome measures at baseline and follow-up 
compared with baseline only were not associated with 
increased biased estimates.24
Analyses of imputed data were done by intention to 
treat. Regression analysis was used to assess diff erences 
between the study groups in primary and secondary 
outcomes, with adjustment for baseline scores.25 We did 
random eff ects regression analyses with maximum 
likelihood estimation, using the Stata xtmixed command, 
to take team-level clustering into account. The model was 
also adjusted for wave to refl ect the stratifi ed design. We 
used prospective α allocation to correct for type I error 
infl ation due to multiple comparisons.26 We set the 
experiment-wise α level at 0·10, the signifi cance level for 
testing the primary outcome set at 0·05, and α=0·004 for 
each of the secondary outcomes (ie, α=0·05/14 secondary 
outcomes=0·004). Scores screening was implemented 
before analyses and model diagnostics were done after 
regression analyses.
Sensitivity analyses were done with adjustment for 
sociodemographic covariates which could be associated 
with our outcomes.27 These covariates, recorded at base-
line, were sex, age, years using mental health services, 
ethnic origin (white British vs other), accommodation 
type (privately owned and rented vs other), marital status 
(single vs relationship), and education (higher education 
vs non-higher education). These covariates were entered 
simultaneously into the regression model to assess 
whether results were modifi ed.
Finally, we did post-hoc analyses relating to partici-
pation. Staff  participation data were calculated only for 
staff  who did not move teams and who had baseline and 
follow-up ratings. To assess whether staff  participation at 
Figure: Trial profi le
30 teams and 1077 patients assessed for eligibility
3 teams excluded
1 ineligible
2 declined
674 patients excluded
409 did not meet inclusion criteria
265 declined
27 teams and 403 participants randomised
14 teams and 210 participants allocated to  
REFOCUS intervention
13 teams and 193 participants allocated to 
 control
55 patients lost to follow-up
34 refused
10 lost contact
8 too unwell
3 died
47 patients lost to follow-up
32 refused
8 lost contact
4 too unwell
3 died
13 teams and 146 patients  followed up14 teams and 155 patients followed up
2 patients missing data 2 patients missing data
14 teams and 153 patients included in analysis 13 teams and 144 patients included in analysis
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the team level was associated with QPR follow-up scores, 
adjusted for baseline scores, we extrapolated a measure 
of team participation by pooling the ratings on the 
participation scale for staff  in each team (α=0·89). We 
used a median split to dichotomise intervention teams 
into high or low participation, which allowed the variable 
team partici pation (control, low participation, or high 
participation) to be extrapolated. We used a median split 
on the participation scale to identify low and high 
participating staff  within the intervention group, allowing 
extrapolation of a staff  participation variable (control, low 
parti cipation, or high participation). We regressed 
patients’ outcomes (missing data estimated with scale 
guidelines or prorated where less than 20% of items 
were missing) by team partici pation, staff  process 
measures, and staff  participation. We used the Stata 
xtmixed command to account for clustering at the team 
level. Analyses were adjusted for baseline scores and 
Trust centre. Costs were calculated by combining service-
use data with the unit costs and were compared between 
the two groups for patients with baseline and follow-up 
cost data. We used a bootstrapped regression model to 
correct for potential skewing of data and to control for 
baseline costs. Costs are reported in 2012/13 UK pounds. 
This trial is registered, number ISRCTN02507940.
Role of the funding source
The funder had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all the data 
in the study and had fi nal responsibility for the decision 
to submit for publication.
Results
27 teams (18 from SLaM and nine from 2gether) and 
403 patients were randomised (fi gure, appendix). Teams 
com prised 13 recovery teams providing long-term support 
to patients with complex health and social needs (nine in 
the REFOCUS group and four in the control group), four 
psychosis teams specialising in work with patients with 
psychosis and complex needs (two and two), three high-
support forensic teams for patients with complex needs 
and risk issues (two and one), three assertive outreach 
teams for hard-to-engage patients (all in the control 
REFOCUS group 
(n=210)
Control group 
(n=193)
Patients’ characteristics
Sex
Male 131 (63%) 127 (66%)
Female 78 (37%) 66 (34%)
Ethnicity
White 115 (56%) 95 (49%)
Non-white 92 (44%) 98 (51%)
Accommodation
Privately owned or rented 48 (23%) 22 (12%)
Supported 161 (77%) 168 (88%)
Relationship
Single 151 (72%) 158 (82%)
In a relationship 59 (28%) 35 (18%)
Education
Secondary 111 (54%) 95 (50%)
Higher 96 (46%) 96 (50%)
Age (years) 44·87 (10·22) 42·99 (11·56)
Use of mental health services (years) 16·13 (11·49) 15·52 (10·89)
Patient-rated outcome scores
QPR (n=365)
Total 38·53 (9·31) 38·97 (9·10)
Intrapersonal 43·77 (10·18) 43·95 (10·10)
Interpersonal 13·55 (2·43) 12·94 (2·67)
CANSAS-P
Met needs (n=390) 3·98 (3·33) 3·66 (2·82)
Unmet needs (n=390) 3·54 (3·01) 3·58 (2·79)
HHI (n=362) 35·25 (4·81) 35·92 (4·94)
MANSA (n=275) 4·75 (0·97) 4·60 (0·88)
MHCS (n=335) 65·23 (14·40) 66·38 (14·63)
WEMWBS (n=373) 47·39 (9·51) 46·68 (10·36)
(Table 1 continues in next column)
REFOCUS group 
(n=210)
Control group 
(n=193)
(Continued from previous page)
Patient-rated experience scores
CSQ (n=380) 25·24 (5·25) 25·51 (5·08)
INSPIRE
Relationship (n=377) 77·77 (17·55) 76·76 (14·95)
Support (n=396) 65·41 (21·48) 59·39 (20·68)
Staff -rated outcome scores
BPRS (n=349) 33·63 (10·13) 31·90 (9·17)
CANSAS-S
Met needs (n=387) 5·80 (3·67) 5·74 (3·52)
Unmet needs (n=387) 3·19 (2·82) 3·50 (2·79)
GAF (n=379) 64·66 (13·88) 64·15 (14·84)
HoNOS (n=366) 8·05 (5·08) 10·45 (6·44)
Process outcome scores
RKI 2·97 (0·38) 2·94 (0·40)
MICA 30·47 (6·96) 31·37 (6·96)
RPS
Skills 2·79 (0·64) 2·73 (0·66)
Behavioural intent 1·66 (0·34) 1·68 (0·37)
Behaviour 1·78 (0·78) 1·74 (0·77)
Data are number (%) or mean (SD). QPR=Questionnaire about the Process of 
Recovery. CANSAS-P=Camberwell Assessment of Needs Short Appraisal Schedule-
Patient. HHI=Herth Hope Index. MANSA=Manchester Short Assessment of Quality 
of Life. MHCS=Mental Health Confi dence Scale. WEMWBS=Warwick-Edinburgh 
Mental Well-Being Scale. CSQ=Client Satisfaction Questionnaire. BPRS=Brief 
Psychiatric Rating Scale. CANSAS-S=Camberwell Assessment of Needs Short 
Appraisal Schedule-Staff . GAF=Global Assessment of Functioning. HoNOS=Health 
of the Nation Outcome Scale. RKI=Recovery Knowledge Inventory. MICA=Mental 
Illness: Clinicians’ Attitudes. RPS=Recovery Practice Scale.
Table 1: Baseline sociodemographic and clinical characteristics 
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group), two supported-living teams for patients in 
supported accommodation (both in the control group), 
one low-support team for patients with less-complex 
needs (in the REFOCUS group), and one early-inter-
vention team for patients in the fi rst 3–5 years after 
psychosis being diagnosed (in the control group).
Baseline characteristics of patients are shown in table 1. 
Patients in the intervention group were signifi cantly 
more likely to live in privately owned or rented accom-
modation, to be in a relationship, and to be unemployed 
than those in the control group, although signifi cance 
was lost after Bonferroni adjustment to account for 
multiple com parisons. The control group had higher 
social disability scores on HoNOS (p<0·0001), but did 
not diff er signifi cantly from the REFOCUS group for any 
other characteristics.
14 intervention briefi ng sessions were run by researchers 
for patients and carers and 14 for staff . Attendance per 
meeting ranged from 0 to 25 patients, and from 50% to 
80% of staff  per team. 41 of the planned 42 personal 
recovery training sessions were run, with a median 
attendance of 14·4 (range 8–24) team members in session 
one, 13·1 (4–21) in session two, and 10·4 (6–15) in session 
three. All the planned 42 coaching training sessions were 
run, with attendance of 14·7 (12–21) team members in 
session one, 12·0 (7–19) in session two, and 11·3 (5–24) in 
session three. The proportions of staff  attending training 
sessions cannot easily be quantifi ed because high staff  
turnover rates complicate the denominator, but most staff  
seem to have attended training.
12 of the intended 36 externally facilitated team 
refl ection groups were run, with median attendance of 
10·0 (range 5–21) team members per session. No formal 
records were kept of the non-facilitated team or team-
manager refl ection groups, due to limited capacity in the 
research team, but few, if any, sessions seem to have 
happened. Reasons for reduced engagement were low 
team motivation and logistical challenges (eg, diffi  culties 
in obtaining cover for whole-team sessions and staff  being 
busy). We had no evidence of supervision refl ection forms 
being used in supervision sessions.
Overall, fi ve of the intended 14 partnership projects were 
run. These comprised building a website, organising a 
Christmas party, and providing an infor mation session for 
a group of patients with SLaM, and an Olympics sports day 
and a 3-day outward-bound course with 2Gether. Towards 
the end of the trial, two teams (one in the REFOCUS group 
and one in the control group) disbanded but follow-up data 
were obtained from patients and paired staff .
Data were available for 532 staff  at baseline, follow-up, or 
both. Of these, 336 were in the same team at baseline and 
follow-up, 105 left after baseline, 70 joined before follow-
up, and 21 moved between teams (nine to a team in the 
same study group, eight from the REFOCUS group to the 
control group, and four from the control group to the 
REFOCUS group). Six patients (three in the REFOCUS 
group and three in the control group) died during the 
study period, all for reasons identifi ed as unrelated to the 
intervention by their clinicians. These patients were 
excluded from the analysis. Some adverse events were 
reported (three deaths in each group) but none was 
deemed to be due to the intervention.
Missing data were estimated for all but the six patients 
who died during follow-up. Therefore, at 1-year follow-up, 
QPR data were available for 275 (69%) of 397 patients 
(appendix). Missing data across QPR scales was not 
associated with any sociodemographic covariate and was 
only associated with CANSAS-P met needs among the 
clinical measures (patients with complete QPR data had 
higher scores for met needs at baseline than those with 
missing data, p=0·02), although the diff erence became 
non-signifi cant after adjustment for multiple pairwise 
comparisons. Data for secondary outcomes were available 
for 60–91% of patients (appendix).
121 patients in the control group and 134 in the 
REFOCUS group had complete data. QPR mean scores 
were stable between baseline and follow-up in the two 
Regression Intracluster 
correlation
b (p value) 95% CI
Patient-rated outcome scores
QPR
Total 0·63 (p=0·55) –1·41 to 2·67 0
Interpersonal 0·13 (p=0·75) –0·93 to 0·67 0·05
Intrapersonal 0·49 (p=0·44) –1·71 to 2·70 0
CANSAS-P
Met needs 0·43 (p=0·43) –0·63 to 1·49 0·10
Unmet needs –0·31 (p=0·41) –1·04 to 0·42 0·03
HHI 0·65 (p=0·30) –0·59 to 1·88 0·03
MANSA –0·04 (p=0·73) –0·27 to 0·19 0·01
MHCS 2·00 (p=0·23) –1·23 to 5·22 0·03
WEMWBS 0·76 (p=0·51) –1·50 to 3·01 0·01
Patient-rated experience scores
CSQ 0·71 (p=0·20) –0·38 to 1·79 0
INSPIRE
Support –2·43 (p=0·41) –8·22 to 3·36 0·01
Relationship –0·39 (p=0·86) –4·66 to 3·88 0
Staff -rated outcome scores
BPRS –1·85 (p=0·15) –4·37 to 0·66 0·12
CANSAS-S
Met needs 0·07 (p=0·91) –1·29 to 1·16 0·13
Unmet needs –0·80 (p=0·03) –1·52 to –0·65 0·10
GAF 5·90 (p<0·0001) 2·61 to 9·18 0·01
HoNOS –1·21 (p=0·07) –2·53 to 0·10 0·04
Total number of patients 397 (207 REFOCUS group, 190 controls). QPR=questionnaire about the process of 
recovery. CANSAS-P=Camberwell Assessment of Needs short appraisal schedule-patient. HHI=Herth Hope index. 
MANSA=Manchester Short Assessment of Quality of Life. MHCS=Mental Health Confi dence Scale. 
WEMWBS=Warwick-Edinburgh Mental Well-Being Scale. CSQ=Client Satisfaction Questionnaire. BPRS=Brief 
Psychiatric Rating Scale. CANSAS-S=Camberwell Assessment of Needs Short Appraisal Schedule-Staff . GAF=Global 
Assessment of Functioning. HoNOS=Health of the Nation Outcome Scale. 
Table 2: Comparison of outcomes between full imputed groups at follow-up, adjusted for baseline 
scores and wave 
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study groups for the total score (control baseline 38·6 [SD 
9·5] vs follow-up 40·2 [10·3]; intervention 38·5 [9·8] vs 
40·6 [10·1]), the intrapersonal subscale (control 43·6 [10·6] 
vs 45·5 [10·3]; intervention 43·7[10·6] vs 46·1 [11·1]), and 
the interpersonal subscale (control 13·1 [2·8] vs 13·4 [2·7]; 
intervention 13·6 [2·2] vs 13·8 [2·6]).
In the intention-to-treat analysis (397 participants from 
27 teams, mean cluster size 15, range 13–17) the QPR total, 
intrapersonal, and interpersonal scores did not diff er 
between groups at follow-up (table 2). The only diff erences 
in secondary out comes at follow-up were improved scores 
for GAF and CANSAS-S in the REFOCUS group (table 2), 
although the latter was non-signifi cant after α adjustment 
for multiple comparisons.
After adjustment for covariates, eff ect sizes were 
weakened for CANSAS-S unmet needs (–0·68, 95% CI 
–1·42 to –0·006) and GAF (5·32, 2·03 to 8·61; appendix). 
Patterns were not modifi ed across the other scales. 
Analysis of complete cases in the intention-to-treat 
population produced an equivalent pattern of results to 
that with imputed data (appendix).
We found an eff ect of team on the QPR interpersonal 
subscale, Herth Hope Index, MANSA, Mental Health 
Confi dence Scale, Brief Psychiatric Rating Scale, GAF, and 
CANSAS-P and CANSAS-S scores (table 2). Assessment of 
residuals revealed some skewing in client satisfaction 
question naire scores, and the results were confi rmed with 
use of bootstrap SE (data not shown).
As part of our post-hoc analysis we explored the 
association between team participation and follow-up QPR 
score (average cluster size 11, range 7–14). We found that 
QPR interpersonal scores adjusted for baseline varied by 
team participation. Patients receiving care from high-
participation teams had signifi cantly higher QPR 
Number of patients and mean (SE) score Overall Control vs low 
participation 
(b, p value 
[95% CI])
Control vs high 
participation 
(b, p value 
[95% CI])
Low vs high 
participation 
(b, p value 
[95% CI])
Control REFOCUS low 
participation
REFOCUS high 
participation
RKI 129, 2·92 (0·03) 72, 2·89 (0·04) 56, 2·99 (0·04) χ2=2·95*, p=0·23 –0·03, p=0·49 
(–0·12 to 0·06)
0·06, p=0·22 
(–0·04 to 0·16)
–0·09, p=0·09 
(–0·20 to 0·01)
MICA 131, 30·12 (0·55) 72, 30·78 (0·73) 58, 30·65 (0·82) χ2=0·59*, p=0·75 0·66, p=0·48 
(–1·16 to 2·49)
0·53, p=0·60 
(–1·46 to 2·52)
0·13, p=0·90 
(–2·02 to 2·29)
RPS
Skills 114, 2·87 (0·06) 66, 2·74 (0·08) 50, 2·95 (0·09) χ2=3·49*, p=0·17 –0·14, p=0·16 
(–0·33 to 0·05)
0·07, p=0·33 
(–0·14 to 0·29)
–0·21, p=0·08 
(–0·45 to 0·02)
Behavioural intent 114, 1·67 (0·03) 66, 1·60 (0·04) 50, 1·68 (0·05) χ2=2·24*, p=0·33 –0·07, p=0·18 
(–0·18 to 0·03)
0·01, p=0·87 
(–0·11 to 0·13)
–0·08, p=0·21 
(–0·21 to 0·05)
Behaviour 114, 1·80 (0·07) 66, 1·54 (0·09) 50, 1·97 (0·10) χ2=10·92*, p=0·004 –0·26, p=0·02 
(–0·48 to –0·05)
0·16, p=0·18 
(–0·08 to 0·40)
–0·43, p=0·001 
(–0·69 to –0·16)
RKI=Recovery Knowledge Inventory. MICA=Mental Illness: Clinicians’ Attitudes. RPS=Recovery Practice Scale. *Two degrees of freedom. 
Table 4: Relation between team-level participation and staff -rated knowledge, attitudes, and behaviour, adjusted for baseline scores
Number of patients and mean (SE) score Overall Control vs low 
participation 
(b, p value 
[95% CI])
Control vs high 
participation 
(b, p value 
[95% CI])
Low vs high 
participation 
(b, p value 
[95% CI])
Control REFOCUS low 
participation
REFOCUS high 
participation
QPR
Total 144, 40·01 (0·59) 67, 40·74 (1·08) 74, 41·30 (0·96) χ2=1·57*, p=0·46 0·74, p=0·55 
(–1·70 to 3·18)
1·29, p=0·26 
(–0·94 to 3·53)
–0·56, p=0·73 
(–3·77 to 2·66)
Interpersonal 144, 13·54 (0·20) 67, 12·82 (0·37) 74, 14·39 (0·33) χ2=8·23*, p=0·02 –0·72, p=0·09 
(–1·54 to 0·11)
0·85, p=0·03 
(0·09 to 1·62)
–1·57, p=0·005 
(–2·66 to –0·48)
Intrapersonal 144, 45·36 (0·65) 67, 46·18 (1·18) 74, 46·58 (1·06) χ2=1·23*, p=0·54 0·82, p=0·60 
(–1·87 to 3·50)
1·21, p=0·33 
(–1·24 to 3·67)
–0·40, p=0·83 
(–3·93 to 3·14)
GAF 169, 62·3 (1·07) 53, 67·1 (2·17) 82, 69·3 (1·76) χ2=14·60*, p=0·0007 4·8, p=0.051 
(–0·01 to 9·58)
–7·0 p=0·001 
(–11·07 to 2·98)
–2·24, p=0·47 
(–8·31 to 3·82)
HoNOS 168, 10·1 (0·41) 59, 7·8 (0·79) 78, 10·1 (0·67) χ2=6·71*, p=0·03 –2·32, p=0·01 
(–4·08 to 0·56)
–0·04, p=0·96 
(–1·60 to 1·51)
–2·36, p=0·041 
(–4·62 to –0·10)
QPR=Questionnaire about the Process of Recovery. GAF=Global Assessment of Functioning. HoNOS=Health of the Nation Outcome Scale. *Two degrees of freedom. 
Table 3: Relation between team-level participation and patient-rated recovery, adjusted for baseline scores 
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interpersonal scores at follow-up than did those receiving 
care from low-participation teams (table 3). The intracluster 
correlation coeffi  cient was 0 for all QPR scales. High-
participation teams also had better results in two secondary 
outcomes, HoNOS (although this became non-signifi cant 
after Bonferroni adjustment) and GAF (table 3). No other 
eff ect on secondary outcomes was found.
To understand why recovery-supporting relationships 
might be improved in teams that had higher participation, 
we investigated staff  changes in recovery knowledge 
(average cluster size 10, range 4–18), attitudes towards 
mental illness (average cluster size 10, range 5–17), and 
self-rated adherence (average cluster size 9, range 4–16; 
table 4). The intracluster correlation co effi  cient was 0 for 
all measures. Participation level by staff  was not 
associated with adjusted follow-up scores on MICA and 
RKI. High staff  participation, however, was associated 
with signifi cantly higher scores for self-rated recovery-
promotion behaviour than less participation (table 4).
Service use in the 6 months before baseline and the 
6 months before 1-year follow-up was analysed for a 
subsample of 266 patients with available data (table 5). 
Contact with general practitioners and care coordinators 
was substantial. The intensity of the use of some services 
at baseline and follow-up varied notably. For example, the 
number of contacts with occupational therapists rose from 
eight to 50 in the REFOCUS group, but the number of 
patients in this category was small. Around two-thirds of 
patients had contact with psychiatrists at baseline, but this 
fell slightly to 55% for the REFOCUS group by follow-up. 
Around a quarter of patients in both groups had contact 
with support workers during each period. At baseline 
around half of all patients had day-care contact, but the 
proportion fell to 38% for both groups by follow-up.
The mean overall intervention cost was £120 (appendix), 
but this varied from £22 to £357. The most expensive 
service was psychiatric inpatient care even though it was 
used by relatively few participants (4% in the REFOCUS 
group and 6% in the control group). Total service-use 
costs were lower for patients in the REFOCUS group 
than in the control group, at baseline (£2997 vs £3754) 
and follow-up (£2752 vs £3853). After adjustment for 
baseline costs, the cost diff erence between the REFOCUS 
and control groups was £1062 (95% CI –1103 to 3017) in 
favour of the intervention, but the diff erence was not 
signifi cant. Service costs were on average £657 less for 
patients receiving care from high-participation teams in 
the REFOCUS group than those for patients receiving 
care from low-participation teams in the REFOCUS 
group (95% CI –1555 to 4783), but this diff erence was also 
not signifi cant. Owing to the non-signifi cant diff erences 
in costs and the primary outcome, further cost-
eff ectiveness analyses were not done.
Discussion
In 27 community-based adult mental health teams in two 
NHS Trusts in England, we found no signifi cant eff ect of 
the REFOCUS intervention on recovery in patients with 
psychosis compared with usual treatment. Most secon-
dary outcomes did not diff er, with the exceptions of 
improved functioning (which remained signifi cant after 
adjustment for multiple testing) and staff -rated unmet 
needs (which became non-signifi cant after adjustment) 
in the REFOCUS group. Although we found no evidence 
Service use at baseline Service use at follow-up Contacts at baseline Contacts at follow-up
REFOCUS 
group
(n=139) 
Control 
group 
(n=127)
REFOCUS 
group
(n=139) 
Control 
group 
(n=127) 
REFOCUS 
group
Control
group
REFOCUS 
group
Control
group
General practictioner 116 (84%) 98 (77%) 115 (83%) 104 (82%) 3·5 (3·3) 3·7 (4·0) 3·2 (3·1) 3·3 (5·0)
Care coordinator 129 (93%) 125 (98%) 113 (81%) 113 (89%) 10·4 (7·7) 14·9 (13·0) 8·2 (7·1) 12·1 (12·9)
Psychiatrist 92 (66%) 77 (61%) 76 (55%) 82 (65%) 2·9 (3·1) 2·6 (2·8) 2·3 (2·5) 2·4 (2·1)
Other doctor 29 (21%) 27 (21%) 23 (17%) 18 (14%) 2·3 (1·4) 5·6 (17·0) 2·6 (2·2) 2·1 (1·1)
Psychologist 15 (11%) 21 (17%) 12 (9%) 17 (13%) 8·1 (8·8) 8·6 (10·0) 6·0 (7·0) 10·4 (9·7)
Social worker 14 (10%) 13 (10%) 9 (7%) 3 (2%) 8·1 (8·5) 3·9 (3·8) 6·9 (7·4) 13·3 (9·5)
Nurse 13 (9%) 16 (13%) 20 (14%) 21 (17%) 6·6 (6·9) 19·9 (44·0) 14·2 (39·1) 18·0 (37·8)
Occupational therapist 10 (7%) 13 (10%) 4 (3%) 10 (8%) 7·8 (10·2) 8·5 (10·5) 49·5 (87·3) 5·4 (7·5)
Support worker 30 (22%) 32 (25%) 29 (21%) 32 (25%) 29·3 (47·1) 24·4 (21·6) 45·2 (60·1) 57·6 (64·2)
Vocational worker 18 (13%) 8 (6%) 11 (8%) 9 (7%) 5·4 (6·1) 4·8 (7·5) 4·1 (4·8) 29·3 (58·5)
Drug and alcohol adviser 6 (4%) 5 (4%) 5 (4%) 4 (3%) 4·7 (4·3) 15·0 (18·9) 14·0 (12·5) 18·5 (20·4)
Other therapist 8 (6%) 11 (9%) 7 (5%) 5 (4%) 13·0 (11·9) 27·5 (53·4) 9·7 (8·2) 16·4 (13·1)
Psychiatric health inpatient 13 (9%) 10 (8%) 6 (4%) 7 (6%) 30·6 (20·8) 44·0 (50·8) 59·7 (75·1) 67·3 (65·3)
Physical health inpatient 6 (4%) 6 (5%) 7 (5%) 13 (10%) 3·5 (2·3) 3·4 (4·0) 6·0 (7·1) 7·7 (16·3)
Specialist team 12 (9%) 16 (13%) 7 (5%) 10 (8%) 14·3 (19·3) 20·9 (34·3) 9·6 (9·5) 13·0 (10·6)
Day care 72 (52%) 57 (45%) 53 (38%) 48 (38%) 36·0 (61·4) 28·9 (31·3) 36·3 (45·1) 35·7 (42·9)
Data are number (%) or mean (SD).
Table 5: Service use in the 6 months before baseline and the 6 months before 1-year follow-up 
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of changes in staff  knowledge, skills, or attitudes, scores 
for self-reported recovery-promotion behaviour were 
higher for staff  in high-participation teams than for those 
in low-participation teams. Consistent with this fi nd-
ing, patients receiving care from high-participation 
REFOCUS teams had higher scores on the QPR inter-
personal subscale than those receiving care from low-
participation REFOCUS teams. Finally, the REFOCUS 
intervention was associated with reduced care costs, 
although the diff erence was not signifi cant.
We off er several explanations for the lack of improve-
ment in the primary outcome. First, and the explanation 
we favour, is that the intervention was inadequately 
implemented. Staff  participation (ie, physical presence 
and full engagement in training) was self-rated by staff  
who were aware of study group allocation because 
blinding was not possible in this study. Team members 
might, therefore, have been susceptible to social 
desirability bias, leading to rating themselves as more 
engaged than was actually the case. The bias, however, 
might be slight, because there is no obvious reason why 
it would not aff ect all staff  across the REFOCUS group, 
leading to infl ation rather than bias. Additionally, 
recovery was rated by patients. Despite the possibility of 
bias, higher participation was associated with an increase 
in staff -reported recovery-promotion behaviours and 
patient-reported recovery in the QPR interpersonal 
subscale. The qualitative assessment of process 
(experiences of staff )28 showed that implementation 
barriers occurred at the individual, team, and organis-
ation levels. Implementation of treatment guide lines 
within specialist mental health services is frequently 
poor,29 and faces three translational hindrances: adoption 
in principle, early implementation, and persistence of 
implementation.30 Although policy supports the imple-
mentation of recovery-promotion inter ventions (adoption 
in principle), early imple mentation will not necessarily 
follow. Broader implementation strategies are needed, 
including leadership and an organisational culture.31
Second, the REFOCUS intervention might be in-
eff ective in its primary aim of improving personal 
recovery within the 1-year time frame of the intervention. 
Indeed, the original REFOCUS intervention was 
18 months and was shortened due to diffi  culty in 
recruiting patients. The patients in this study had been 
using mental health services, on average, for more 
than 15 years, which suggests settled staff –patient 
relationships. Other studies have shown that trusting 
relationships between patients and staff  can take longer 
to form than is available with short-term interventions.32 
Future research to assess the REFOCUS intervention 
with an inception cohort of new referrals might be useful 
to investigate the eff ects in less-established staff –patient 
relationships. Similarly, com parison between diff erent 
groups of workers (eg, multidisciplinary versus single-
discipline teams or teams with and without peer support 
workers) would enable assessment of contamination at 
the level of staff  and and of interaction between worker 
roles and implementation.
Third, the existing practice of staff  in the control group 
might already have promoted recovery, as, despite the 
staff  in the control group receiving no formal REFOCUS 
training and the intervention manual being available 
online, we found no diff erence in primary outcome 
between study groups and little evidence of contamination 
due to staff  movement. Many staff  in SLaM teams in 
both study groups would have previously had some 
recovery training33 and, therefore, sustained changes in 
the control group cannot be excluded. Nevertheless, the 
recovery orientation of participating teams, as measured 
by RKI (control mean 2·94, intervention mean 2·97), was 
lower than the mean RKI score of 3·94 found in an 
Australian study,34 which suggests there was not a high 
recovery orientation at baseline.
Finally, although the choice of endpoint assessment was 
based on recommendations from a systematic review,19 
the QPR has not previously been used as a primary 
outcome in a trial, and its sensitivity to change has not 
been fully established. This measure might, therefore, 
have been insuffi  ciently responsive to detect change. 
Assessment of the process of recovery with the outcome-
oriented methods of evidence-based medicine seems to be 
intrinsically problematic and more socio logical approaches 
are needed.35 A qualitative assess ment of the experience of 
patients in this study showed that eff ective implementation 
was associated with positive changes in process (more 
open and collaborative relationships with staff ), hope, and 
empowerment (to be published later), which highlights 
the challenges of measuring the eff ects of complex inter-
ventions. As a minimum, further psychometric assess-
ment of QPR and other candidate recovery measures is 
indicated.
In relation to the protocol,14 this report addresses the 
fi rst objective of assessing intervention eff ectiveness. 
The main protocol deviation was that eff orts to estimate 
the degree of masking for researchers at follow-up were 
abandoned when it became clear they could not be kept 
unaware of team allocation status. Validation of the 
REFOCUS model is addressed in published36 and 
submitted process evaluation papers, optimisation of 
trial parameters is addressed in this report and a revised 
REFOCUS intervention manual,37 and the relation 
between clinical and recovery outcomes is addressed in a 
report to be published later.
This study has several strengths. The intervention is 
theory based and the mixed methods for assessment in 
routine clinical settings across two sites included a 
range of quantitative and qualitative approaches to 
investigate adherence, intermediate processes, and 
outcomes. The clinical population is representative of 
patients seen in the real world, although the inclusion 
criterion of clinical judgment about patients being well 
enough to participate (to allow consideration of the full 
range of reasons why being approached to participate 
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might not be appropriate) and the good social 
functioning indicated by GAF and HoNOS scores 
might have led to the most disabled people not having 
participated. The full range of adult mental health 
teams typically provided in NHS Trusts was included, 
which maximises repre sentativeness. 
A limitation of the study is the absence of a pilot study 
to inform implementation, which might have identifi ed 
in advance the challenges presented by practice changes, 
such as high staff  turnover within teams with low morale 
due to reorganisation within the NHS Trusts. Application 
of a structured assessment of feasibility36 indicated 
that the intervention involves several implementation 
barriers, including staff  training, complexity, human 
resources, and staff  time. We identifi ed organisational 
leadership and stability plus readiness to change at team 
level as predictors of implementation,28 which could 
provide criteria for inclusion of high-implementing 
teams in future evaluations. A second limitation is the 
recruitment shortfall. The analysable sample comprised 
297 patients, compared with the target of 336, which 
was due mainly to a higher attrition rate (26%) than 
anticipated at follow-up. 88% recruitment could mean 
that the study was underpowered to detect diff erences 
between study groups. Third, the design did not include 
analyses stratifi ed by team type, which raises the 
possibility of diff erential implementation. The relation 
between team type and outcome was not analysed in 
this study because of the uneven allocation and because 
categories were derived from team names and, 
therefore, might have overlapped. Future trials might 
more formally establish team types and use either a 
homogeneous sample or stratify the analysis by team 
type.
This study contributes to the wider context (panel), and 
has several clinical implications. From the staff  perspective, 
eff orts to support recovery could lead to improved 
functioning and might also reduce unmet needs for people 
with psychosis (although not from the patient’s perspective). 
Conversations between staff  and patients about values, 
treatment preferences, and strengths might translate over 
time into changes in functioning and assessed need. The 
diff erences we found in this study between groups do not 
seem to have been mediated through changes in the 
recovery variables studied, which suggests a complex 
relation between these variables. If the positive eff ect of 
high participation teams is not due to staff  bias in rating 
implementation, the REFOCUS intervention has the 
potential to be an eff ective recovery-promotion intervention 
if implementation barriers can be addressed. At the societal 
level, antistigma campaigns improve attainment of valued 
social roles.46 Within mental health services, the challenge 
might be to embed in organisational culture an expectation 
of partnership-based staff –patient relationships and to 
focus on the values and treatment preferences, strengths, 
and goals of patients. Fully supporting recovery, therefore, 
might require inter ventions across the whole mental health 
service, including the patient as an active partner and 
involving a com bination of evidence-based patient-level 
interventions,5 team-level interventions, such as REFOCUS, 
and organisational transformation approaches.47
Panel: Research in context
Systematic review
REFOCUS is a team-level intervention aimed at improving mental health service support 
for patients’ recovery.9 Development of the REFOCUS intervention was informed by 
primary research and secondary systematic reviews done to address knowledge gaps. To 
understand how recovery is supported, we did an inductive, semantic-level, thematic 
analysis of 30 international documents describing best recovery-promoting practice, 
which identifi ed four practice domains.12 The REFOCUS intervention targets the 
supporting recovery and working relationships practice domains, and does not target the 
promoting citizenship and organisational commitment practice domains. To identify 
recovery processes to target with this intervention, we did a systematic review. We 
searched the AMED, BNI, Embase, Medline, PsycINFO, SSP, CINAHL, IBSS, ASSIA, BHI, 
sociological abstracts, and SSA databases for articles published from inception to 2009, 
manually searched three journals, and searched other web-based sources.38 We used the 
search terms (“mental health” OR “mental illness$” OR “mental disorder” OR “mental 
disease” OR “mental problem” OR “psychol$ health” OR “psychol$ illness$” OR “psychol$ 
disorder” OR “psychol$ problem” OR “psychiatr$ health”, OR “psychiatr$ illness$” OR 
“psychiatr$ disorder” OR “psychiatr$ problem”) AND “recover$” AND (“theor$” OR 
“framework” OR “model” OR “dimension” OR “paradigm” OR “concept$” OR “theme$” 
OR “stages” OR “processes”). Additional search parameters were English language and 
either secondary research synthesising the available literature or primary research 
involving quantitative or qualitative data based on at least three participants. After rating 
the quality of retrieved articles with established tools, we used narrative synthesis to 
identify the recovery processes of the connectedness, hope, identity, meaning, and 
empowerment (CHIME) framework. The CHIME framework was subsequently validated 
with current service users39 and across diff erent cultures.40 To identify the best measure to 
use in strengths assessment (working practice 2), we systematically reviewed measures of 
strengths.41 To identify the optimum primary outcome we systematically reviewed 
measures of recovery.19 To inform the development of the new INSPIRE measure42 we 
systematically reviewed measures of recovery support.43 To understand staff  perspectives, 
we developed a grounded theory of staff  experiences of supporting recovery.16 To 
maximise the feasibility of the intervention, we developed a new measure of feasibility 
based on implementation science research36 and an understanding of social eff ects on 
recovery.44 We used expert consultation with patients, carers, staff , and researchers (n=56) 
to develop the REFOCUS intervention, the REFOCUS model,9 and the choice of secondary 
outcomes in the REFOCUS trial.14 The full theory base and development of the REFOCUS 
intervention are described elsewhere.45
Interpretation
We assessed whether implementation of REFOCUS aff ected staff -rated and patient-rated 
outcomes in comparison with routine mental health care provided to patients with 
psychosis. We found no signifi cant eff ect on the primary outcome of recovery and, of the 
secondary outcomes, functioning (which remained signifi cant after adjustment for 
multiple testing) and staff -rated unmet needs (which became non-signifi cant after 
adjustment) were improved in the REFOCUS group. The most likely explanation for the 
absence of improvement in recovery is inadequate implementation, because higher staff  
participation led to higher scores for staff -rated recovery-promoting behaviour and 
patient-rated interpersonal aspects of recovery than lower participation. Our fi ndings 
indicate that attention needs to be paid to the organisational commitment practice 
domain to ensure that support of recovery is organisationally viewed as core business 
rather than an additional task for mental health services. 
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